AbbVie has achieved a 400% return on investment, significantly outperforming the S&P 500 by 139%. This performance highlights the company's strong lead over the broader market.
AbbVie's strong returns suggest robust company performance and potentially a successful strategy that has resonated with investors, offering a compelling alternative to broad market index investing.
AbbVie has demonstrated exceptional performance, delivering returns of 400%. This figure represents a substantial outperformance compared to the broader market, as measured by the S&P 500, which it beat by 139%. The company's performance indicates a significant lead over the general market index.
Pick the topics you care about. Get only what matters, on your cadence.
Trading stocks, CFDs, spread betting, futures, and options involves a high level of risk and may not be suitable for all investors. Prices can move rapidly, and losses can occur quickly and exceed your expectations.
